Atropine vs spectacles: Which move will be more powerful in the game of myopia management?

Published on June 5, 2025
An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.
Continue reading on website
Other news

Japanese researchers develop contact lenses that shield eye from radiation

June 5, 2025
The technology addresses concerns about electromagnetic radiation exposure linked to the development of smart contact lenses

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

June 5, 2025
The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.